Skip to main content

Jodi Lipof, M.D.

Contact Information

Phone Numbers

Appointment: (585) 276-3000

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting




MD | George Washington University Hospital (USA)

Post-doctoral Training & Residency

07/01/2018 - 06/30/2021
Fellowship in Hematology & Oncology at University of Rochester Medical Center

06/25/2016 - 06/24/2018
Residency in Internal Medicine at University of Rochester Medical Center

06/10/2015 - 06/24/2016
Internship in Internal Medicine at University of Rochester Medical Center

VIEW ALL expand_more

Clinical Trials

Selinexor for the Treatment of Patients With Intermediate and High-Risk Smoldering Multiple Myeloma

Lead Researcher: Jodi Lipof

Selinexor is a drug that has been approved in the treatment of patients with symptomatic multiple myeloma. The standard of care for patients with Smoldering Multiple Myeloma remains observation, but there are numerous clinical trials investigating interventions to delay progression to multiple myeloma and prevent or delay disease related outcomes. A subset of patients with intermediate or high risk smoldering multiple myeloma have a much higher risk of progressive to multiple myeloma, while the low risk smoldering myeloma patient population has a much lower risk. This is a clinical trial investigating the use of low-dose selinexor in patients with intermediate to high-risk smoldering multiple myeloma. The investigators hypothesize that the use of selinexor in intermediate to high risk smoldering myeloma patients will help to delay progression of disease to symptomatic multiple myeloma.

View Study Details


Journal Articles

Lipof JJ, Huselton EJ, Zent CS, Evans A, Zhang B, Rothberg PG, Bennett JM. "A Case of Acute Eosinophilic Leukemia with a Novel 6 Mutation." Case reports in hematology.. 2021 2021:5574766. Epub 2021 Jul 03.

Lipof JJ, Barr PM. "Early Progression of Follicular Lymphoma: Biology and Treatment." Hematology/oncology clinics of North America.. 2020 Aug; 34(4):757-769. Epub 2020 May 05.

Lipof JJ, Loh KP, O'Dwyer K, Liesveld JL. "Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia." Cancers.. 2018 Jun 4; 10(6)Epub 2018 Jun 04.